Subscribe to these results:

Upcoming Workshops

For All Cancers

  1. May18Clinical Trials: How They Transform the Treatment of Cancer
    Register

For Breast Cancer

  1. Jun29HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
    Register

For Head and Neck Cancer

  1. Jun 1Oral, Head & Neck Cancer: Treatment Update
    Register

For Liver Cancer

  1. Jun27Liver Cancer: Treatment Updates
    Register

For Mantle Cell Lymphoma

  1. May25Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    Register

For Mesothelioma

  1. Jun13Mesothelioma: Innovative Treatment Options
    Register

Past workshops

For All Cancers

    1. Managing the Side Effects of Immunotherapy
      Part II of New Trends in Immunotherapy
    2. Understanding the Role of Immunotherapy in Treating Cancer
      Part I of New Trends in Immunotherapy
    3. Clinical Trials: How They Transform the Treatment of Cancer
    4. Update on Clinical Trials: How They Work
    5. New Perspectives in Clinical Trial Research

For Acute Lymphoblastic Leukemia

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Acute Myeloid Leukemia

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Basal Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers

For Bladder Cancer

    1. Bladder Cancer: Treatment Updates
      Part I of Life with Bladder Cancer

For Bone Cancer

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Brain Cancer

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment

For Breast Cancer

    1. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    2. HER2-Positive Metastatic Breast Cancer: New Therapies
    3. Metastatic Breast Cancer: Treatment Updates
    4. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    5. The Benefits of Clinical Trials for Triple Negative Breast Cancer

For Chronic Lymphocytic Leukemia

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Chronic Lymphocytic Leukemia: Current Treatment Perspectives
      Part II of Living with Chronic Lymphocytic Leukemia
    3. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Chronic Myelogenous Leukemia

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Colorectal Cancer

    1. Colorectal Cancer Treatment: Progress & Advances
    2. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Equity. Every Patient. Every Day. Everywhere.

For Cutaneous T-Cell Lymphoma

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Diffuse Large B-Cell Lymphoma

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Diffuse Large B-Cell Lymphoma (DLBCL) Updates
    3. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Follicular Lymphoma

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Glioblastoma

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment

For Head and Neck Cancer

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment

For Hodgkin Lymphoma

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Leukemia

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Chronic Lymphocytic Leukemia: Current Treatment Perspectives
      Part II of Living with Chronic Lymphocytic Leukemia
    3. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    4. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Equity. Every Patient. Every Day. Everywhere.

For Lung Cancer

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Equity. Every Patient. Every Day. Everywhere.

For Lymphoma

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Diffuse Large B-Cell Lymphoma (DLBCL) Updates
    3. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    4. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Equity. Every Patient. Every Day. Everywhere.

For Mantle Cell Lymphoma

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Marginal Zone Lymphoma

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Melanoma

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Equity. Every Patient. Every Day. Everywhere.

For Mesothelioma

    1. Mesothelioma: Innovative Treatment Options

For Metastatic Breast Cancer

    1. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    2. HER2-Positive Metastatic Breast Cancer: New Therapies
    3. Metastatic Breast Cancer: Treatment Updates
    4. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment

For Multiple Myeloma

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Myelodysplastic Syndromes

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Equity. Every Patient. Every Day. Everywhere.

For Myeloproliferative Neoplasms

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Equity. Every Patient. Every Day. Everywhere.

For Non-Hodgkin Lymphoma

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Ovarian Cancer

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment

For Pancreatic Cancer

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part II of Equity. Every Patient. Every Day. Everywhere.

For Peripheral T-Cell Lymphoma

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Prostate Cancer

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment

For Sarcoma

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment

For Skin Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers

For Small Lymphocytic Lymphoma

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Squamous Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers

For Triple Negative Breast Cancer

    1. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    2. HER2-Positive Metastatic Breast Cancer: New Therapies
    3. Metastatic Breast Cancer: Treatment Updates
    4. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    5. The Benefits of Clinical Trials for Triple Negative Breast Cancer
Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.